Chemocentryx reported $-22123000 in EBIT for its second fiscal quarter of 2020.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Alexion Pharmaceuticals ALXN:US $ 687.7M 45.1M
Alnylam Pharmaceuticals ALNY:US $ -225199000 26.34M
Amgen AMGN:US $ 2323M 32M
AstraZeneca AZN:LN 1.44B 25M
Bayer BAYN:GR 160M 153.8M
Biogen BIIB:US $ 1159.4M 850.9M
Biomarin Pharmaceutical BMRN:US $ -4326200 8.49M
Bristol Myers Squibb BMY:US $ 1565M 226M
GlaxoSmithKline GSK:LN 155.3M 93.5M
Glaxosmithkline GSK:US 2.47B 919M
Johnson & Johnson JNJ:US $ 6201M 1990M
Macrogenics MGNX:US $ -47310000 1.86M
Merk MRK:US $ 3722M 955M
Novartis NOVN:VX 2.92B 199M
Pfizer PFE:US $ 3852M 972M
Sarepta Therapeutics SRPT:US $ -138353000 20.33M
Takeda 4502:JP 90.02B 101.16B
Teva Pharmaceutical TEVA:IT 71.8M 1.2M
YTE INCY:US $ 25.01M 90.53M